Michael Yan, MD MPH

@MichaelYanMD

🇨🇦 |Radiation Oncologist @RadMedPM @PMcancercentre @UofTdro | Alumnus @Sunnybrook @QueensOncology @JohnsHopkinsSPH @SchulichMedDent | Views = mine

Toronto, Ontario Joined January 2012

466 Following 416 Followers 273 Posts

Latest posts 5

Michael Yan, MD MPH @MichaelYanMD Nov 27, 2025

Absolute pleasure hosting @lauren_henke @APrice_BeamOn and learning from world leaders in adaptive RT. Innovative as always, and inspiration to leverage tech to move the needle and improve patient outcomes.

Lauren Henke, MD, MSCI @lauren_henke Nov 27, 2025

Wonderful to get to visit friends @RadMedPM 🇨🇦 + rep @RadOncUH w/ @APrice_BeamOn 💪🏼Hard to beat company like @ldawsonmd @j_lukovic @MichaelYanMD et al, getting to be part of their annual GI SBRT course, & even getting to talk about pancreas RT on World Pancreatic Cancer Day 💜 Thanks for having us! @caseccc @UH_RE_Institute

View quoted post on X

Michael Yan, MD MPH @MichaelYanMD Apr 6, 2025

Amazing work, look forward to enrolling patients on trial!

Alex Price @APrice_BeamOn Apr 6, 2025

Hot out of the adaptive research oven!! Huge congrats to one of our rock star residents, @Betyguevarasoto for her awesome work in @IJROBP for direct-to-unit/sim-free RT in highly complex treatment settings. Clinical trial opening soon by @lauren_henke @MichaelYanMD !! @RadOncUH

View quoted post on X

Michael Yan, MD MPH @MichaelYanMD Jan 9, 2025

We hope to show exercise is safe and feasible despite bone metastases. Look forward to this multidisciplinary collaboration.

C. Jillian Tsai, MD, PhD @CJTsaiMDPhD Jan 9, 2025

🆕📢 Can patients with bone mets benefit from structured exercise regimen after radiation? The EXERT-BM trial, led by our junior faculty @MichaelYanMD @RadMedPM @pmcancercentre and sponsored by our own Palliative RT and Oligomet Program (PROP), is aimed to answer this crucial question! This a collaborative effort with @PMCancerRehab and orthopedic program to enhance overall patient care. 🙏

View quoted post on X

Michael Yan, MD MPH @MichaelYanMD Dec 26, 2024

Thanks for the tweetorial @jryckman3 and sharing our work. Locoregional options may be promising alternatives/adjuncts to systemic therapy in this challenging patient population. Looking forward to future combinatory trials.

Jeff Ryckman Verified account @jryckman3 Dec 26, 2024

10/ TL;DR: Surgery and SBRT both offer meaningful options for advanced HCC with MVI, each with unique strengths. Personalizing treatment through multidisciplinary discussions is key to supporting patients in their journey. 💡

#HCC #HPCSM #LiverTwitter #RadOnc #RTOG1112

View quoted post on X

Michael Yan, MD MPH @MichaelYanMD Dec 19, 2024

Great day for HCC, with two very important rad onc trials to improve care for these patients.
@RadMedPM @pmcancercentre @BCLC_group @ldawsonmd @UofTDRO @thePMCF @UHN_Research